Greenspoon Marder Client Alert: FDA Extends Comment Period for Public Hearing on Cannabis-Derived Compounds
Jun 21, 2019
Jessica Wasserman, Esq.
The FDA Office of Legislastion has decided to extend the comment period regarding their May 31st public hearing, “Scientific Data and Information bout Products Containing Cannabis or Cannabis-Derived Compounds,” so that comments may now be submitted on or before
July 16, 2019.
The FDA has stated that they are very interested in additional data regarding safety and dosages of CBD products, to the extent that folks are interested in sharing that information with the agency. For instructions regarding comment submissions, please see the following Federal Register Notice.
For more information on CBD, see
this statement from Dr. Amy Abernethy, Principal Deputy Commissioner, and Lowell Schiller, Principal Associate Commissioner for Policy. The FDA has also provided an update for consumers here.
For any further inquiries contact Greenspoon Marder Partner,
Jessica Wasserman, at (202) 669-9449 or email@example.com.
About Greenspoon Marder
Greenspoon Marder is a national full-service business law firm with 240 attorneys and 26 locations across the United States. We are ranked amongst
American Lawyer’s Am Law 200, as one of the top law firms in the U.S. since 2015. Since our inception in 1981, our firm has been committed to providing excellent client service through our cross-disciplinary, client-team approach. Our mission is to understand the challenges that our clients face, build collaborative relationships, and craft creative solutions designed and executed with long-term strategic goals in mind. We serve Fortune 500, middle-market public and private companies, start-ups, emerging businesses, individuals and entrepreneurs nationwide.
Natalie Villanueva, Marketing/ PR Manager
954.333.4308 | firstname.lastname@example.org